Emapalumab Effective in Rheumatologic Disease–Associated HLH

Emapalumab-containing regimens showed positive outcomes in patients with rheumatologic disease–associated hemophagocytic lymphohistiocytosis, a rare and life-threatening disorder.
Medscape Medical News